Page 1494 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1494

Chapter 83  Virus-Associated Lymphoma  1329


            Keegan TH, Glaser SL, Clarke CA, et al: Epstein-Barr virus as a marker of   Rudek MA, Flexner C, Ambinder RF: Use of antineoplastic agents in patients
              survival  after  Hodgkin’s  lymphoma:  a  population-based  study.  J  Clin   with cancer who have HIV/AIDS. Lancet Oncol 12:905, 2011.
              Oncol 23:7604, 2005.                                Savoldo B, Goss JA, Hammer MM, et al: Treatment of solid organ transplant
            Kelly GL, Rickinson AB: Burkitt lymphoma: revisiting the pathogenesis of   recipients with autologous Epstein Barr virus-specific cytotoxic T lympho-
              a virus-associated malignancy. Hematology Am Soc Hematol Educ Program   cytes (CTLs). Blood 108:2942, 2006.
              2007:277, 2007.                                     Sparano JA, Lee JY, Kaplan LD, et al: Rituximab plus concurrent infusional
            Kitahata  MM,  Achenbach  CJ,  Saag  MS:  Age  at  cancer  diagnosis  among   EPOCH chemotherapy is highly effective in HIV-associated B-cell non-
              persons with AIDS. Ann Intern Med 154:642, 2011.      Hodgkin lymphoma. Blood 115:3008, 2010.
            Levine AM: HIV-associated lymphoma. Blood 115:2986, 2010.  Uldrick TS,  Polizzotto  MN,  Aleman  K,  et al:  High-dose  zidovudine  plus
            Libra M, Polesel J, Russo AE, et al: Extrahepatic disorders of HCV infection:   valganciclovir  for  Kaposi  sarcoma  herpesvirus-associated  multicentric
              a distinct entity of B-cell neoplasia? Int J Oncol 36:1331, 2010.  Castleman disease: a pilot study of virus-activated cytotoxic therapy. Blood
            Matsuoka  M,  Jeang  KT:  Human T-cell  leukaemia  virus  type  1  (HTLV-1)   117:6977, 2011.
              infectivity and cellular transformation. Nat Rev Cancer 7:270, 2007.  Vereide DT, Sugden B: Lymphomas differ in their dependence on Epstein-
            Matsuoka  M,  Jeang  KT:  Human  T-cell  leukemia  virus  type  1  (HTLV-1)   Barr virus. Blood 117:1977, 2011.
              and  leukemic  transformation:  viral  infectivity, Tax,  HBZ  and  therapy.
              Oncogene 30:1379, 2011.
            Moore PS, Chang Y: KSHV: forgotten but not gone. Blood 117:6973, 2011.
            Ratner L, Harrington W, Feng X, et al: Human T cell leukemia virus reactiva-  REFERENCES
              tion  with  progression  of  adult T-cell  leukemia-lymphoma.  PLoS  ONE
              4:e4420, 2009.                                      For the complete list of references, log on to www.expertconsult.com.
   1489   1490   1491   1492   1493   1494   1495   1496   1497   1498   1499